Suven Life Sciences Limited
Suven Life Sciences Limited, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1989, the company has established itself as a leader in drug discovery and development, focusing on central nervous system disorders and other therapeutic areas. With a robust portfolio of innovative products and services, Suven Life Sciences is renowned for its unique approach to developing novel compounds that address unmet medical needs. The company has achieved significant milestones, including successful collaborations and partnerships that enhance its market position. Operating primarily in India and expanding its reach globally, Suven Life Sciences continues to make strides in the industry, driven by a commitment to research excellence and patient-centric solutions.
DitchCarbon Score
How does Suven Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Suven Life Sciences Limited's score of 26 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Suven Life Sciences Limited's reported carbon emissions
In 2024, Suven Life Sciences Limited reported total carbon emissions of approximately 888,615 kg CO2e, comprising 30,539 kg CO2e from Scope 1 and 858,076 kg CO2e from Scope 2 emissions. This represents a slight decrease in emissions compared to 2023, where the company recorded about 864,567 kg CO2e, with 31,483 kg CO2e from Scope 1 and 833,084 kg CO2e from Scope 2. In 2022, the total emissions were approximately 890,219 kg CO2e, with 31,101 kg CO2e from Scope 1 and 859,118 kg CO2e from Scope 2. Suven Life Sciences has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or climate pledges. The company has consistently reported its emissions for Scope 1 and Scope 2, indicating a commitment to transparency in its climate impact. The emissions intensity per rupee of turnover has been reported but lacks specific numerical values. Overall, while Suven Life Sciences Limited has shown a commitment to monitoring its carbon footprint, further details on reduction initiatives or targets would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 31,101 | 00,000 | 00,000 |
| Scope 2 | 859,118 | 000,000 | 000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Suven Life Sciences Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
